Thank you for attending our virtual event! We will contact attendees when the presentation videos are available on the IEEE Resource Center.

       LIVE EVENTS

TOPICAL PLENARIES      WORKSHOPS

        Challenges

IEEE ISBI 2020

International Symposium on Biomedical Imaging

April 3-7, 2020

The IEEE International Symposium on Biomedical Imaging (ISBI) is a scientific conference dedicated to mathematical, algorithmic, and computational aspects of biological and biomedical imaging, across all scales of observation. It fosters knowledge transfer among different imaging communities and contributes to an integrative approach to biomedical imaging.

ISBI is a joint initiative from the IEEE Signal Processing Society (SPS) and the IEEE Engineering in Medicine and Biology Society (EMBS). The 2020 meeting will include tutorials, challenges and a scientific program composed of plenary talks, workshops, as well as oral and poster presentations of peer-reviewed papers..

Keynote Speakers

Michael D. Abràmoff, MD PhD

Keynote Speaker

University of Iowa

Contact Card

Michael D. Abràmoff, MD PhD

Biography

Dr. Michael D. Abramoff, MD, PhD, is a fellowship-trained retina specialist, computer scientist and entrepreneur. He is Founder and CEO of IDx, the first company ever to receive FDA clearance for an autonomous AI diagnostic system. In this capacity, as an expert on AI in healthcare, he has been invited to brief the US Congress, the White House and the Federal Trade Commission. He continues to treat patients with retinal disease and trains medical students, residents, and fellows, as well as engineering graduate students at the University of Iowa.

Dr. Abramoff has published over 260 peer reviewed journal papers (h-index 58) on AI, image analysis, and retinal diseases, and many book chapters, that have been cited over 27,000 times. He is the inventor on 17 patents and 5 patent applications on AI, medical imaging and image analysis. In 2010, Dr. Abramoff’s research findings led him to found IDx, to bring to patients more affordable, more accessible, and higher quality healthcare.

IDx is a leading AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. The company is focused on developing clinically-aligned autonomous AI. By enabling diagnostic assessment in primary care settings, IDx aims to increase patient access to high-quality, affordable disease detection. In 2018, IDx became the first company ever to receive FDA clearance for an autonomous AI diagnostic system. The system, called IDx-DR, detects diabetic retinopathy without requiring a physician to interpret the results.

Positions & Affiliations

Outdated or incorrect contact information? Please contact us with the correct information.